Cargando…
Molnupiravir; molecular and functional descriptors of mitochondrial safety
Molnupiravir is an orally active nucleoside analog antiviral drug that recently was approved by the U.S. FDA for emergency treatment of adult patients infected with the SARS-CoV-2 (COVID-19) virus and at risk for severe progression. The active form of the drug, N-hydroxycytidine (NHC) triphosphate c...
Autores principales: | Wallace, K.B., Bjork, J.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958731/ https://www.ncbi.nlm.nih.gov/pubmed/35358570 http://dx.doi.org/10.1016/j.taap.2022.116003 |
Ejemplares similares
-
Remdesivir; molecular and functional measures of mitochondrial safety
por: Bjork, J.A., et al.
Publicado: (2021) -
Efficacy and safety of molnupiravir for COVID-19 patients
por: Fatima, Maurish, et al.
Publicado: (2022) -
Computational Analysis of Molnupiravir
por: Sharov, Artem V., et al.
Publicado: (2022) -
Efficacy and Safety of Molnupiravir in Mild COVID-19 Patients in India
por: Sinha, Shubhadeep, et al.
Publicado: (2022) -
Molnupiravir: First Approval
por: Syed, Yahiya Y.
Publicado: (2022)